BIOLOGICAL HAZARDS RISK ASSESSMENT

Slides:



Advertisements
Similar presentations
National Emerging Infectious Diseases Laboratories Risk Assessment
Advertisements

OVERVIEW OF INDUSTRIAL HYGIENE UNIVERSITY OF HOUSTON – DOWNTOWN CAMPUS.
The Chain of Infection. As healthcare professionals, it is important to understand two facts about infection As healthcare professionals, it is important.
2008 In-Service Law Enforcement Training Training Objectives Explain the purpose of the Bloodborne Pathogen Standard in 29 CFR Describe the.
Purpose of 2005 Guidelines Update and replace 1994 Mycobacterium tuberculosis infection control (IC) guidelines Further reduce threat to health-care workers.
Biosafety in Microbiologic and Biomedical Laboratories The University of Texas at Tyler IACUC Education and Training *Note: Content not specific to UT.
Biosafety in the TB Laboratory
Laboratory Biosafety Pathogenic Microbiology and Virology Laboratories.
Occupational Safety and Health Course for Healthcare Professionals.
Copyright © 2006 Thomson Delmar Learning. ALL RIGHTS RESERVED. 1 PowerPoint ® Presentation for Introduction to Dental Assisting Module: Disease Prevention.
Nueces County Safety Training Training Objectives Explain the purpose of the Bloodborne Pathogen Standard in 29 CFR Describe the general symptoms.
Bloodborne Pathogens. What are Bloodborne Pathogens? Bloodborne Pathogens Bacteria Virus.
OSHAs blood borne pathogens standard A written exposure control plan designed to eliminate or minimize worker exposure Compliance with universal precautions.
Siobhan Prout, BSAP1 Infection Prevention & Control.
INFECTION CONTROL AND STANDARD PRECAUTIONS
Risk Group and Biosafety Level. Classification of Infective Agents by Risk Group Pathogenicity Pathogenicity Infectious Dose Infectious Dose Mode of Transmission.
Bloodborne Pathogens. Training Topics  Review terminology related to exposure control  Review bloodborne pathogens  Review vector-borne hazards  Review.
Infection Prevention and Control Competencies for Healthcare Personnel Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious Diseases.
Disease Transmission In Dentistry By DR. Shahzadi Tayyaba Hashmi DNT 231.
It’s safety and I know it!. The Chain of Infection.
Biosafety in the Clinical Microbiology Lab Mohammad Rahbar (PhD) Associated Professor Iranian Health Reference Laboratory.
What is infection? An illness caused by the spread of micro-organisms (bacteria, viruses, fungi or parasites) to humans from other humans, animals or the.
CJO3 EOC Review Unit 1 - Crime Scene Safety O – Discuss the potential health and safety hazards one could encounter at a crime scene.
Pan American Health Organization.. Protecting the Health of Health Care Workers: Experience from the Americas Marie-Claude Lavoie Decision Making for Using.
Prevent Disease – Promote Wellness – Improve Quality of Life UNIVERSAL/STANDARD PRECAUTIONS BLOODBORNE PATHOGENS Michigan Department of Community Health.
Part F Blood and fluid exposure Exposure? Injury with sharp object. Contamination of open wound with blood or body fluid. Eye or mucosal splash with.
Copyright  Business & Legal Reports, Inc. BLR’s Safety Training Presentations Bloodborne Pathogens 29 CFR
Disease Transmission In Dentistry Dr. Shahzadi Tayyaba Hashmi
Risk Assessment. Risk As defined by Kaplan and Garrick, risk analysis consists of answering three specific questions: what can happen? what is the chance.
Chapter 3: Infection Control Outline Disease Transmission and Occupational Exposure Infection Control Agencies and Regulations Infection Control Techniques.
Bloodborne Pathogens First Responder. Know the regulation 29 CFR a.
Introduction to Biohazards: Risk Management
Discuss the major characteristics of the four Biosafety Levels. Define “Risk Group” and give an example of each. Discuss how Risk Groups are used in conjunction.
Safety organization and training. The biosafety officer and biosafety committee A safety policy, A safety manual, and Supporting programmes for their.
1 CHCOHS312A Follow safety procedures for direct care work.
Bloodborne Pathogens. What are Bloodborne Pathogens? Bloodborne Pathogens Bacteria Virus.
The Management of infection control & personal hygiene.
Bloodborne Pathogens Training: Preventing Disease Transmission
SAFETY IN MEDICAL LAB.
52 Table 1. Summary of Recommended Biosafety Levels for Infectious Agents. Biosafety Level Agents Practices Safety Equipment (Primary Barriers) Facilities.
 Occupational Health and Safety Administration (OSHA) is a federal agency that works to promote safety in all health care environments.  OSHA creates.
BIOSAFETY LEVEL 2 AWARENESS TRAINING UW Stout Laboratory Safety Biological Safety.
Standard and Transmission-Based Precautions
Course Code: NUR 240 Lecture ( 3). 1.The Risk of Infection is always Present in every Hospital. 2.Identify frequency of nosocomial infection.
Hazardous Chemicals In The Laboratory A Guide for Their Safe Use and Disposal.
Chain of infection 1 Prof. Hamed Adetunji. Course Overview At the end of this lecture and the activities that follow, student will be able to: List the.
Objectives  Define risk assessment as it relates to biosafety  Understand the risk assessment process and how to implement it  Discuss risk factors.
The IBC is: The Institutional Biosafety Committee (aka Biohazards Committee)
Biological Agents, Biosafety cabinets and Beyond Biological Agents, Biosafety cabinets and Beyond Microbiology laboratory 2005.
RCSD Bloodborne Pathogen Protection Program Presented by Suzanne Wheatcraft, MS, CPG Director of School Environmental Health & Safety.
These materials have been developed based on applicable federal laws and regulations in place at the time the materials were created. The program is being.
The Chain of Infection.
The Chain of Infection.
Comply with Infection Control Policies and Procedures in Health Work
The Chain of Infection.
ROLE OF THE INSTITUTIONAL BIOSAFETY COMMITTEE
CHAPTER 15 Biological Hazards.
The Chain of Infection.
PROTECTION FROM INJURY AND DISEASE
IACUC Occupational Health & Safety Programs
List of experts Rome, May 24.
The Chain of Infection.
BSL-1 Laboratory BIOHAZARD
Bloodborne Pathogens in Healthcare
The Chain of Infection.
Chapter 2 Safety and Wellness
Chapter 70 Management of Patients With Infectious Diseases
Chapter 2 Safety and Wellness
Chapter 2 Safety and Wellness
Biosafety Principles: Separation, Seclusion & Containment
Presentation transcript:

BIOLOGICAL HAZARDS RISK ASSESSMENT Prepared by; Miss Syazwani Mahmad Puzi School of Bioprocess Engineering UniMAP

Biological Hazards Risk Assessment Biological Hazards Risk Assessment is a process used to identify the hazardous characteristics of a known infectious or potentially infectious agent or material, the activities that can result in a person’s exposure to an agent, the likelihood that such exposure will cause a LAI, and the probable consequences of such an infection. The information identified by risk assessment will provide a guide for the selection of appropriate biosafety levels and microbiological practices, safety equipment, and facility safeguards that can prevent LAIs.

Biological Hazards Risk Assessment is used to alert staffs to the hazards of working with infectious agents and to the need for developing proficiency in the use of selected safe practices and containment equipment. Successful control of hazards in the laboratory also protects persons not directly associated with the laboratory, such as other occupants of the same building, and the public.

The primary factors to consider in risk assessment and selection of precautions fall into two broad categories: -agent hazards and laboratory procedure hazards. In addition, the capability of the laboratory staff to control hazards must be considered. This capability will depend on the training, technical proficiency, and good habits of all members of the laboratory, and the operational integrity of containment equipment and facility safeguards.

Hazardous Characteristics of an Agent The principal hazardous characteristics of an agent are: its capability to infect and cause disease in a susceptible human or animal host, its virulence as measured by the severity of disease, and the availability of preventive measures and effective treatments for the disease. The World Health Organization (WHO) has recommended an agent risk group classification for laboratory use that describes four general risk groups based on these principal characteristics and the route of transmission of the natural disease.

The four groups address the risk to both the laboratory worker and the community. The NIH Guidelines established a comparable classification and assigned human etiological agents into four risk groups on the basis of hazard

The predominant probable routes of transmission in the laboratory are: direct skin, eye or mucosal membrane exposure to an agent; parenteral inoculation by a syringe needle or other contaminated sharp, or by bites from infected animals and arthropod vectors; 3) ingestion of liquid suspension of an infectious agent, or by contaminated hand to mouth exposure; and 4) inhalation of infectious aerosols.

An awareness of the routes of transmission for the natural human disease is helpful in identifying probable routes of transmission in the laboratory and the potential for any risk to the public health. For example, transmission of infectious agents can occur by direct contact with discharges from respiratory mucous membranes of infected persons, which would be a clear indication that a laboratory worker is at risk of infection from mucosal membrane exposure to droplets generated while handling that agent.

An Approach to Assess Risks and Select Appropriate Safeguards

1. Identify Agent Hazards And Perform An Initial Assessment Of Risk Consider the principal hazardous characteristics of the agent, which include its capability to infect and cause disease in a susceptible human host, severity of disease, and the availability of preventive measures and effective treatments.

2. Identify Laboratory Procedure Hazards The principal laboratory procedure hazards are agent concentration, suspension volume, equipment and procedures that generate small particle aerosols and larger airborne particles (droplets), and use of sharps. Procedures involving animals can present a number of hazards such as bites and scratches, exposure to zoonotic agents, and the handling of experimentally generated infectious aerosols.

3. Make A Determination Of The Appropriate Biosafety Level And Select Additional Precautions Indicated By The Risk Assessment The selection of the appropriate biosafety level and the selection of any additional laboratory precautions require a comprehensive understanding of the practices, safety equipment, and facility safeguards

4. Evaluate The Proficiencies Of Staff Regarding Safe Practices And The Integrity Of Safety Equipment The protection of laboratory workers, other persons associated with the laboratory, and the public will depend ultimately on the laboratory workers themselves. In conducting a risk assessment, the laboratory director or principal investigator should ensure that laboratory workers have acquired the technical proficiency in the use of microbiological practices and safety equipment required for the safe handling of the agent, and have developed good habits that sustain excellence in the performance of those practices. An evaluation of a person’s training, experience in handling infectious agents, proficiency in the use of sterile techniques and BSCs, ability to respond to emergencies, and willingness to accept responsibility for protecting one’s self and others is important insurance that a laboratory worker is capable of working safely.

5. Review The Risk Assessment With A Biosafety Professional and Subject Matter Expert A review of the risk assessment and selected safeguards by knowledgeable individuals is always beneficial and sometimes required by regulatory or funding agencies, as is the case with the NIH Guidelines. Adopting this step voluntarily will promote the use of safe practices in work with hazardous agents in microbiological and biomedical laboratories.